RxDoctor Payments Data

Noelani Gonzalez-Ortiz, MD

Dermatology · San Juan, PRNPI 1255607222

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $125,384 of the $153,627 with a category attached, or 81.6%. AbbVie accounts for 92.2% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $60,898, more than ten times the $340 reported in 2019. Among dermatology clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$153,627in general payments, 2019–2025

Across 127 payments — averaging $1209.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$142K
  • E.r. Squibb & Sons, L.L.C.$8K
  • Merz North America, Inc.$2K
  • Galderma Laboratories, L.p.$2K
  • Sanofi$85
  • Johnson & Johnson$80
  • plus $76 from 3 others

What the payments were for

  • Consulting fees$14,84310%
  • Speaking & faculty fees$125,38482%
  • Travel & lodging$9,1796%
  • Food & beverage$4,1373%
  • Education$840%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$153,627 in reported general payments places this provider in the 95th percentile of 108 dermatology providers in Puerto Rico.

See all dermatology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$3,845
Medicare patients
11
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluocinonide13$505
Ketoconazole21$416
Triamcinolone Acetonide11$78

Paid to pharmacies, not to this prescriber.

Other dermatology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →